The Market for Pharmaceuticals in Brazil, Russia, India & China 2008

Table of Contents

Brazil Pharmaceutical Market Intelligence Report

• EXECUTIVE SUMMARY
• PHARMACEUTICAL MARKET
• Current Size
• Projections
• Market Structure
  • Pharmacy Sector
  • Public Sector
  • OTC Medicines
  • Generic Medicines
  • Domestic Production
    • Trade Associations
  • Imports
  • Exports
  • Research & Development
• Market Developments
  • More competition in the OTC sector
  • Serious problems for pharmacy chain
  • Clinical development of dengue vaccine
  • Fighting HIV/AIDS
  • Novartis' manufacturing expansion plans
  • Zydus Cadila' s acquisition of Brazil' s Nikkho
  • EMS' manufacturing expansion plans
  • Programme to subsidise contraception
  • Novo Nordisk' s manufacturing expansion plans
  • New drug price readjustments
• KEY NATIONAL DATA PROJECTIONS
• Methodology and Sources

List of Tables

• Summary of the Brazilian Pharmaceutical Market, 2007
• SWOT Analysis of the Brazilian Pharmaceutical Market, 2007
• Espicom Analysis of the Brazilian Healthcare Sector, 2007
• Pharmaceutical Market, 1997-2006
• Pharmaceutical Market by Value per Month, 1999-2006 (R$ 000)
• Pharmaceutical Market by Value per Month, 1999-2006 (US$ 000)
• Pharmaceutical Market by Volume per Month, 1999-2006 (000 Units)
• Pharmacy Sector by Value, 2003-2006
• Outlook for the OTC Industry, 2005-2006
• Generics Pharmacy Sales by Value and Volume, 2000-2006
• Gross Production, 1996-2004
• Gross Production by Leading State, 1997-2004 (R$ Million)
• Workforce, 1997-2004
• Summary of Pharmaceutical Imports, 2001-2005 (US$ Million)
• Raw Materials & Medicaments as Percentage of Pharmaceutical Imports, 2001-2005
• Change in Pharmaceutical Imports, 2000-2004 (%)
• Leading Suppliers by Country/Region, 2005 (US$000)
• Leading Suppliers of Raw Materials, 2005 (US$000)
• Leading Suppliers of Medicaments, 2005 (US$000)
• Imports of Pharmaceuticals, 2001-2005 (US$000s)
• Pharmaceutical Import Trends, 2005 (US$000s)
• Leading Suppliers of Pharmaceuticals, 2005 (US$000s)
• Leading Suppliers by Category, 2005 (US$000s)
• Summary of Pharmaceutical Exports, 2001-2005 (US$ Million)
• Raw Materials & Medicaments as Percentage of Pharmaceutical Exports, 2001-2005
• Change in Pharmaceutical Exports, 2001-2005 (%)
• Leading Destinations of Pharmaceuticals, 2005 (US$000)
• Exports of Pharmaceuticals, 2001-2005 (US$000s)
• Pharmaceutical Export Trends, 2005 (US$000s)
• Pharmaceutical Exports by Leading Destination, 2005 (US$000s)
• Balance of Trade in Pharmaceuticals, 2001-2005 (US$000s)
• Pharmaceutical Investments by Type, 2007
• Key Data, 2007-2012

List of Figures

• Pharmaceutical Market Projections, 2007-2012
• Radar Graph of the Brazilian Healthcare System, 2007
• Pharmaceutical Market, 1997-2006
• Pharmacy Sector by Value, 2003-2006
• Gross Production, 1996-2004
• Number of Producers, 1996-2004
• Workforce, 1996-2004
• Pharmaceutical Balance of Trade, 2001-2005 (US$ Million)

BRAZIL BACKGROUND DATA

• GEOGRAPHY
• POLITICAL OVERVIEW
• ECONOMIC OVERVIEW
  • GDP, 2000-2011
• POPULATION
  • Population, 2000-2011
  • Population by Age Group, July 2000-July 2010 (Million)
  • Population by Region, July 2005-July 2006
• DEMOGRAPHIC INDICATORS
  • Reported Demographic Indicators, 2000-2004
  • Estimated Demographic Indicators, 2000-2007
• MORTALITY
  • Deaths by Selected Cause, 2000-2004
  • Deaths by Selected Cause, 2000-2004 (%)
  • Change in Deaths by Selected Cause, 2000-2004 (%)
  • Detailed Causes of Death, 2004
• Infant Mortality
  • Infant Mortality by Cause, 1999-2004
• MORBIDITY
  • Notified Infectious Diseases, 1999-2005
  • Notified Infectious Diseases, 1999-2005 (%)
  • Change in Notified Infectious Diseases, 1999-2004 (%)
• AIDS
  • Notified Cases of AIDS by Region, 1980-2005
  • Notified Deaths by AIDS, 1980-2004
• Cancer
  • Estimated Cancer Incidence by Site, 2005
• Anaemia

CHARTS

• Map of Brazil
• Notified Deaths by AIDS, 1980-2004 (000)

BRAZIL HEALTHCARE SYSTEM

• ORGANISATION & ADMINISTRATION
  • Ministry of Health' s Organisation, 2006
• HEALTH EXPENDITURE
  • Estimated Health Expenditure, 2003-2012 (US$ Billion)
  • Estimated Health Expenditure by Sector, 2000-2003 (%)
• Public Health Expenditure
  • Public Health Expenditure as % of GDP by Sector, 2000-2003
  • Public Health Expenditure by Sector, 2000-2003 (R$ Billion)
  • Public Health Expenditure by Sector, 2000-2003 (%)
  • Per Capita Public Health Expenditure by Sector, R$ (2000-2003)
  • Public Health Expenditure by Sector & Region, 2003 (R$ Billion)
  • Public Health Expenditure by Sector & Region, 2003 (%)
• HEALTHCARE ESTABLISHMENTS
  • Healthcare Establishments, 1985-2005
  • Healthcare Establishments by State, 1985-2005
  • Healthcare Establishments by Activity & Sector, 1985-2005
  • Healthcare Establishments by Activity & Sector, 1985-2005 (%)
  • Healthcare Establishments by Sector, 1985-2005
  • Healthcare Establishments by State & Sector, 2005
  • Healthcare Establishments by Region & Sector, 2005 (%)
  • Healthcare Establishments by Region & Activity, 2005
  • Healthcare Establishments by Region & Type, 2005
  • Public Healthcare Establishments by Region & Type, 2005
  • Private Healthcare Establishments by Region & Type, 2005
  • Private/SUS Healthcare Establishments by Region & Type, 2005
  • Healthcare Establishments by Region & Level of Contracted Services, 2005
• HOSPITAL SERVICES
  • Healthcare Establishments with Inpatient Facilities by Sector, 1985-2005
  • Healthcare Establishments with Inpatient Facilities by Sector & Region, 2005
  • Healthcare Establishments with Inpatient Facilities by Type & Region, 2005
  • Specialist Healthcare Establishments with Inpatient Facilities by Sector & Region, 2005
  • Healthcare Establishments with Inpatient Facilities, with Specialities, by Sector & Region, 2005
  • General Healthcare Establishments with Inpatient Facilities by Sector & Region, 2005
• SUS Hospitals
  • SUS Establishments with Inpatient Facilities by Sector & Provider, 1997-2003
  • SUS Establishments with Inpatient Facilities by State & Sector, July 2003
• Hospital Beds
  • Hospital Beds by Sector, 1985-2005
  • Hospital Beds by Sector, 1985-2005 (%)
  • Change in Hospital Beds by Sector, 1985-2005 (%)
  • Summary of Hospital Beds by Sector & Region, 2005
  • Summary of Hospital Beds by Sector & Region, 2005 (%)
  • Change in Hospital Beds by Sector & Region, 2002-2005 (%)
  • Hospital Beds by Sector & State, 2005
  • Summary of SUS Hospital Beds by Sector & Region, 2005
  • Summary of SUS Hospital Beds by Sector & Region, 2005 (%)
  • Change in SUS Hospital Beds by Sector & Region, 2002-2005 (%)
  • Hospital Beds by Sector & State, July 2003
  • Hospital Beds by Sector & Speciality, July 2003
  • Hospital Beds by Speciality, 1992-2003
• Hospital Activity
  • Summary of Hospital Admissions by Sector & Region, 2004
  • Summary of Hospital Admissions by Sector & Region, 2004 (%)
  • Change in Hospital Admissions by Sector & Region, 2001-2004 (%)
  • Hospital Admissions by Sector & State, 2004
  • SUS Hospital Admissions by Sector, 2000-2005
  • SUS Hospital Admissions by Sector, 2000-2005 (%)
  • SUS Hospital Admissions by Speciality, 2000-2005
  • SUS Hospital Admissions by Speciality, 2000-2005 (%)
  • Change in SUS Hospital Admissions by Speciality, 2000-2005 (%)
  • SUS Hospital Admissions by Cause Group, 2002-2003
  • SUS Hospital Admissions by Cause Group, 2002-2003 (%)
  • SUS Hospital Inpatients by Cause, 2003
• AMBULATORY CARE
  • Healthcare Establishments with Ambulatory Care by Type & Region, 2005
  • Healthcare Establishments with Ambulatory Care by Type & Region, 2005 (%)
  • Healthcare Establishments with Emergency Services by Region & Specialty, 2005
  • Healthcare Establishments with Emergency Services by Region & Specialty, 2005 (%)
  • Healthcare Establishments with Emergency Services by Specialty, 2005 (%)
  • Healthcare Establishments with Ambulatory & Hospital Care by Sector & Specialty, 2005
  • SUS Ambulatory Network by Type, 2001-2003
  • SUS Ambulatory Network by Type & Region, July 2003
  • SUS Ambulatory Network by Type & Region, July 2003 (%)
  • SUS Outpatient Facilities by Type, 2001-2003
  • SUS Outpatient Facilities by Provider, 2001-2003
• Ambulatory Activity
  • SUS Ambulatory Activity by Region, 1997-2005
  • Summary of SUS Ambulatory Activity by Type of Procedure, 2000-2004 (Billion)
  • Summary of SUS Ambulatory Activity by Type of Procedure, 2000-2004 (%)
  • SUS Ambulatory Activity by Provider, 2003 & 2004
  • SUS Ambulatory Activity by Type of Procedure, 2000-2004
• Second Disease Surveillance & Control Project
• Bahia Health System Reform Project
• Family Health Extension Programme
• MEDICAL EQUIPMENT
  • Healthcare Establishments with Diagnostic & Therapy Services by Sector & Specialty, 2005
  • Healthcare Establishments with Inpatient Facilities by Sector, Type of Service & Equipment, 2005
  • Healthcare Establishments Without Inpatient Facilities by Sector, Type of Service & Equipment, 2005
  • Summary of Medical Equipment, 2005
  • Summary of Medical Equipment by Type of Provider, 2002
  • Summary of Medical Equipment by Type of Provider, 2002 (%)
  • Summary of Medical Equipment by Sector, 2005
  • Summary of Medical Equipment by Sector & Type of Provider, 2002
  • Summary of Medical Equipment by Sector & Type of Provider, 2002 (%)
  • Diagnostic Equipment by Type, 2002-2005
  • Diagnostic Equipment by Region, 2002-2005
  • Diagnostic Equipment by Sector & Type, 2005
  • Diagnostic Equipment by Sector & Region, 2005
  • Optical Equipment by Type, 2002-2005
  • Optical Equipment by Region, 2002-2005
  • Optical Equipment by Sector & Type, 2005
  • Optical Equipment by Sector & Region, 2005
  • Graphical Equipment by Type, 2002-2005
  • Graphical Equipment by Region, 2002-2005
  • Graphical Equipment by Sector & Region, 2005
  • Radiotherapy Equipment, 2002-2005
  • Radiotherapy Equipment by Region, 2002-2005
  • Radiotherapy Equipment by Sector & Region, 2005
  • Life Support Equipment by Type, 2002-2005
  • Life Support Equipment by Region, 2002-2005
  • Life Support Equipment by Sector & Type, 2005
  • Life Support Equipment by Sector & Region, 2005
  • Other Medical Equipment by Sector & Type, 2005
  • Other Medical Equipment by Sector & Region, 2005
• MEDICAL PERSONNEL
  • Summary of Health Personnel, 2002-2005
  • Summary of Health Professionals by Region, 2005
  • Summary of Health Professionals by Region, 2005 (%)
  • Change in Health Professionals by Region, 2002-2005 (%)
  • Summary of Health Professionals by Sector, 2005
  • Summary of Health Professionals by Sector, 2005 (%)
  • Change in Health Professionals by Sector, 2002-2005 (%)
  • Summary of Health Professionals by Region & Sector, 2005
  • Summary of Health Assistants & Technicians by Region, 2005
  • Summary of Health Assistants & Technicians by Sector, 2005
  • Medical Personnel by Occupation, 2002
  • Medical Personnel by Sector & Occupation, 2002
  • Change in Medical Personnel by Occupation, 1999 & 2002

CHARTS

• Healthcare Establishments, 1985-2005
• Healthcare Establishments by Sector, 1985-2005
• Healthcare Establishments by Region, 2005 (%)
• Healthcare Establishments by Sector, 2005 (%)
• Healthcare Establishments by Region & Activity, 2005 (%)
• Healthcare Establishments by Sector & Type, 2005
• Healthcare Establishments by Region & Type, 2005
• Healthcare Establishments by Region & Level of Contracted Services, 2005 (%)
• SUS Hospital Admissions by Sector, 1995-2004 (Million)
• Healthcare Establishments with Ambulatory Care by Type & Region, 2005
• SUS Ambulatory Activity, 1997-2004 (Billion)
• Diagnostic & Therapy Services by Sector & Specialty, 2005 (%)
• Summary of Medical Equipment, 2005
• Summary of Medical Equipment, 2002-2005
• Summary of Medical Equipment by Sector, 2005
• Doctors, 1992-2005
• Summary of Health Professionals by Region, 2005
• Health Professionals by Sector, 2005
• Summary of Health Professionals by Region & Sector, 2005

BRAZIL ACCESSING THE PHARMACEUTICAL MARKET

• INTRODUCTION
• REGULATORY ENVIRONMENT
• MERCOSUR Regulation
• National Regulation
• Registration
  • Exemptions
• Imports
• Clinical Trials
• Labelling & Packaging
• Quality Control
• Advertising
• Patent Protection & Intellectual Property Rights
• Pricing
  • Drug Price Adjustments, 2003-2006 (%)
  • Implications for the industry
  • Excessive taxes on drugs
• DISTRIBUTION CHANNELS
• Distributors
  • Members of ABAFARMA, 2006
  • Distribuidora Farmacêutica Panarello
  • Profarma
  • Profarma' s Operational Indicators, 2003-2006
  • Profarma' s Distribution Centres, 2006
  • Profarma' s Gross Sales, 2003-2006 (R$ Million)
  • Profarma' s Gross Sales, 2003-2006 (US$ Million)
  • Profarma' s Leading Pharmaceutical Suppliers, 2005
  • Distribuidora Santa Cruz
• Pharmacies
  • Regulation
  • Farmácia Popular do Brasil
• Pharmacy & Drugstore Chains
  • ABRAFARMA
  • Members of ABRAFARMA, 2006
  • FEBRAFAR
  • Members of FEBRAFAR by Region, 2006
  • ASSIFARMA
  • ASCOFERJ
• TRADE FAIRS
• ABRADILAN FARMA
• ECONOFARMA
• EXPO PHARMA
• FARMA RACINE EXPO
• FCE PHARMA
• FEIRAFARMA
• Hospitalar
• DOMESTIC PRODUCTION
  • Gross Production, 1996-2004
  • Gross Production by Leading State, 1996-2004 (R$ Million)
  • Workforce, 1996-2004
• Trade Associations
  • ABIMIP
  • Members of ABIMIP, 2006
  • ALANAC
  • Members of ALANAC, 2006
  • ALFOB
  • Members of ALFOB, 2006
  • FEBRAFARMA
  • Members of FEBRAFARMA, 2006
  • INTERFARMA
  • Members of INTERFARMA, 2006
  • Pró-Genéricos
  • Members of Pró-Genéricos, 2006
• Domestic Producers
  • Aché
  • Aché' s & Biosintética' s Gross Revenues by Therapeutic Areas, 2005
  • Therapeutic Areas Covered by Aché & Biosintética, 2005
  • Aché' s Leading Products by Therapeutic Area, 2005
  • Biosintética
  • Biosintética' s Sales, 2001-2004
  • Biosintética' s Pharmaceutical Sales by Therapeutic Areas, 2004
  • Barrenne Industria Farmacêutica
  • Barrenne' s Leading Products, 2005
  • Biolab
  • Cimed
  • Cristália' s Business Units, 2006
  • Cristália' s International Representatives, 2006
  • EMS-SIGMA PHARMA
  • Eurofarma
  • Farmasa
  • JP Indústria Farmacêutica
  • Libbs Farmacêutica
  • Libbs' Pharmaceutical Sales, 2000-2006
  • Medley
  • Medley' s International Agreements, 1992-2005
  • Nortec Química
  • Teuto
  • Vitapan
• Multinational Activity
  • Abbott
  • Allergan
  • Altana
  • AstraZeneca
  • Bayer-Schering
    • Bayer
    • Schering
  • Boehringer Ingelheim
  • Boehringer Ingelheim' s Financial Data, 2002-2005
  • BI' s Leading Product Launches, 2000-2005
  • Bristol-Myers Squibb
  • Eli Lilly
  • Farmalab Chiesi
  • GlaxoSmithKline
  • Merck
  • Merck Sharp & Dohme
  • Novartis
  • Novo Nordisk
  • Pfizer
  • Roche
  • Sanofi-Aventis
  • Sanofi-Aventis' s Launched Pharmaceuticals, 2005
  • Schering Plough
  • Wyeth
• Research & Development
  • 2004-2007 National Industrial Policy
  • Demands by Domestic Pharmaceutical Producers to the Ministry of Science & Technology, 2005
  • Profarma & Progeren
  • Profarma' s Objectives, 2005
• DIRECTORY
• Government Organisations
• Trade Associations

CHARTS

• Gross Production, 1996-2004
• Change in Gross Production, 1997-2004 (%)
• Production by Leading State, 2004 (%)
• Number of Producers, 1996-2004
• Workforce by Leading State, 2004 (%)
• Workforce, 1996-2004
• Aché' s & Biosintética' s Gross Turnover & Number of Products, 2005
• Aché' s Gross Revenues, 2001-2005 (R$ Million)
• Aché' s Gross Revenues, 2001-2005 (US$ Million)
• Biosintética' s Sales, 2001-2004
• Libbs' Pharmaceutical Sales, 2000-2006
• Pfizer' s Projected Sales, 2005-2007

China Pharmaceutical Market Intelligence Report

• EXECUTIVE SUMMARY
• PHARMACEUTICAL MARKET
• Current Size
• Projections
• Outlook
• Market Structure
  • Generics
  • OTC Market
  • Domestic Production
    • 11th Five Year Plan Targets
    • HIV/AIDS drugs
  • Imports
  • Exports
  • Research & Development
    • SFDA initiatives
• Market Developments
  • SFDA shuts down 300 drug & medical device manufacturers
  • Stricter GMP Inspection Guidelines from 2008
  • GSK to invest US$100 million in neuroscience research centre
  • Sanofi-Aventis invests over US$100 million in vaccine plant
  • Drug centre in Shanghai to tackle cancer and diabetes
  • MoH improves basic rural medical care coverage
    • Central Government Adopts Five-Year Health Plan
  • Former SFDA Chief Executed for Corruption
  • Medical Insurance to Cover all Urban Citizens
    • China Sets up Medical Insurance Research Institute
  • China May End Tax Benefits for Foreign Companies
  • China Strives to Wipe Out Bird Flu by 2015
  • China Imposes Stricter Quality Checks on 170,000 Medicines
  • China Considers Sending More Doctors to Rural Areas
  • Almost 500,000 Chinese Die of Hepatitis B Annually
  • Central Government Adopts Five-Year Health Plan
  • Beijing to Build Network for Infectious Diseases Before 2008 Olympics
  • China Bans Exports of Human Organs
  • X-ray Fees Capped at Beijing Hospitals
  • New Rule on Prescription of Drugs Effective May 2007
  • Medical Ads Require Approval of Provincial Health Departments
  • China Seeks Companies to Develop or Produce its New Bird Flu Vaccine
  • Traditional Chinese Medicine
    • Manufacturers
    • China Conducts Research on Toxicity and Side Effects of TCM
  • HIV/AIDS
  • World Bank Projects
    • Tuberculosis Control Project
    • Basic Health Services Project
• KEY NATIONAL DATA PROJECTIONS
• This page left intentionally blank
• Methodology and Sources

List of Tables

• Summary of the Chinese Pharmaceutical Market in 2007
• Projected Pharmaceutical Market, 2007-2012
• SWOT Analysis of the Chinese Pharmaceutical Market
• Espicom Analysis of China' s Health Sector
• Chinese Medical/Pharmaceutical Production, 2002 and 2004
• Summary Pharmaceutical Imports, 2001-2005 (US$000s)
• Leading Suppliers of Raw Materials, 2005 (US$000s)
• Leading Suppliers of Medicaments, 2005 (US$000s)
• Imports of Pharmaceuticals, 2001-2005 (US$000s)
• Import Trends, 2005 (US$000s)
• Leading Suppliers, 2005 (U$000s)
• Leading Suppliers by Category, 2005 (US$000s)
• Summary Pharmaceutical Exports, 2001-2005 (US$000s)
• Exports of Pharmaceuticals 2001-2005
• Leading Destinations, 2005 (U$000s)
• Pharmaceutical Balance of Trade, 2001-2005
• Key Data, 2007-2012

List of Figures

• Pharmaceutical Imports, Exports & Balance of Trade, 2001-2005 (US$000s)
• Total Market Projections, 2007-2012 (US$ billions)
• Per Capita Market Projections, 2007-2012 (US$)
• Radar Graph of the Chinese Healthcare System
• Imports of Raw Materials/Retail Medicaments, 1999-2005 (US$000s)
• Leading Suppliers, 2005 (%)
• Exports by Category, 2005 (%)
• Leading Destinations, 2005 (%)

CHINA BACKGROUND DATA

• Geographic
• Political
• Economic
  • Economic Projections 2007-2012
• Population
  • Population Estimates, 1991-2005
  • Population by Province, December 2005
• Population Growth
• Demographic Indicators
  • Principal Demographic Indicators, 2000-2005
  • Demographic Indicators by Province, 2005
• Mortality
  • Major Causes of Death, 1999
  • Major Causes of Death in Urban Areas, 1999-2005
  • Major Causes of Death in Rural Areas, 1999-2005
• Morbidity
  • Reported Infectious Diseases, 1999-2005 (Rate per 100,000 population)
    • HIV/AIDS
    • Tuberculosis
    • Tobacco

CHINA HEALTHCARE SYSTEM

• ORGANISATION & ADMINISTRATION
• Ministry of Health
  • Hospitals
  • Rural Healthcare
  • Health Insurance
  • New Co-operative Medical Scheme (formerly Rural Co-operative Medical Scheme)
• NCMS Funding and Expenditure 2005
  • Commercial Medical Insurance
  • Red Cross Society of China
• HEALTH EXPENDITURE
  • Total Health Expenditure, 1997-2004 (Yuan billions)
• HOSPITAL SERVICES
• Healthcare Facilities
  • Healthcare Institutions by Type, 2000-2005
  • Healthcare Institutions by Type, 2002
  • Healthcare Institutions by Type and Province, 2005
    • Joint Venture Hospitals
• Hospital Beds
  • Healthcare Beds, 1995-2005 (000s)
  • Number of Beds in Healthcare Institutions by Type, 2001-2005
  • Beds by Region, 2005
    • Private Hospitals
• Hospital Activity
  • Admissions, 2000-2005 (millions)
  • Hospital Admissions by Type (10,000s), 2005
  • Hospital Bed Utilisation Statistics, 1993-2005
• AMBULATORY CARE
  • Outpatient Facilities, 2001-2005
    • Hospital Outpatient Activity
  • Hospital Outpatient Visits, 1999-2005 (millions)
  • Outpatient Visits by Establishment, 2005
  • Outpatient Visits by Type (millions), 2005
• MEDICAL PERSONNEL
  • Medical Personnel (000s), 2001-2005
  • Medical Personnel by Province, 2005

CHINA ACCESSING THE PHARMACEUTICAL MARKET

• INTRODUCTION
• REGULATORY ENVIRONMENT
• Pharmaceutical Registration
  • Revised Provisions for Drug Registration 2007
• State Food and Drug Administration (SFDA)
  • Department of Drug Registration
  • Department of Drug Safety & Inspection
  • Department of Drug Market Compliance
  • Drug Classification
  • Biotech regulation
• New Regulatory Legislation
  • 2001 DAL Amendments
  • The Drug Import Regulation
• GMP Regulations
• Pharmaceutical Registration/Drug Approval Process
  • Clinical trials
  • Quality test
  • Certification
• Packaging Regulations
• Post-market Surveillance
  • Licences of 160 drug firms revoked in 2006
• Pharmaceutical Advertising
• Patent Protection & Intellectual Property Rights
  • Administrative Protection
• Pharmaceutical Pricing and Reimbursement
  • Pricing
  • Pricing Sector Developments
  • Provincial governments
  • Reimbursement Lists
• DISTRIBUTION CHANNELS
  • Distribution System Reform
  • Internet Pharmaceutical Distribution
  • Pharmaceutical retail
• Distributors
  • Chindex
  • Hainan Kangtong Pharmaceutical Co Ltd.
  • Hunan Provincial Medicines & Health Products Import & Export Corp.
  • Shandong Medicines & Health Products Import & Export Corp.
  • Sincer Pharmchem Ltd
  • Sinochem Jiangsu Suzhou Import Export Corp.
  • Tianjin Medicines & Health Products Import & Export Corp.
• DOMESTIC PRODUCTION
  • Chinese Medical/Pharmaceutical Production, 2002 and 2004
    • 11th Five Year Plan Targets
    • HIV/AIDS drugs
• Domestic Producers
  • Anhui Anke Biotech
  • Beijing Four Ring Pharmaceutical Factory
  • Changzhou Siyao Pharmaceuticals Co. Ltd
  • China Pharmaceutical Enterprise
  • Dragon Pharmaceuticals
  • Dragon Pharmaceuticals Revenues by Segment, 2006 (US$ millions)
  • Fuzhou Antibiotic Group Corp
  • Haizhou Pharmaceutical Co. Ltd
  • Harbin Pharmaceutical Group Co. Ltd
  • Heshuo Ephedrine Factory
  • Huazhong Pharmaceutical Co. Ltd
  • Jiangsu Jiangan Pharmaceutical Corp Ltd
  • Jiuyuan
  • Livzon (Group) Libao Biochemical & Pharmaceutical Co Ltd
  • Ningbo Jierfu Pharmaceutical Co Ltd
  • North China Pharmaceutical Huasheng Co. Ltd
  • Shenyang Sunshine Pharmaceutical Co Ltd
  • Shenzhen Kexing Biotech
  • Shenzhen Zhijun Pharmaceutical Company
  • Shenzhen Taitai Pharmaceutical Industry (Taitai)
  • Sinovac Biotech Ltd.
  • Wenzhou Pharmaceutical Factory
  • Xiamen No.2 Pharmaceutical Factory
  • Xi' an Pharmaceutical Factory
  • Xinhua Pharma
  • Yiyuan Pharmaceutical Co Ltd
  • Zhejiang Jinhua Lixin Fine Chemicals Co Ltd
• Multinational Producers
  • Allergan
  • Antibioticos
  • Astellas Pharma
  • AstraZeneca
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Daiichi Sankyo
  • Eisai
  • Eli Lilly
  • GlaxoSmithKline
  • Johnson & Johnson
  • Laboratories Servier
  • Merck KGaA
  • Merck Sharp & Dohme
  • Novartis
  • Novo Nordisk
  • Pfizer
  • Ranbaxy
  • Rexim SA (Degussa)
  • Roche
  • Sanofi-Synthèlabo
  • Schering-Plough
  • Takeda
  • Tanabe
  • Watson
  • Wyeth
• Research & Development
  • SFDA initiatives
  • Zhangjiang Hi-Tech Park
  • Beijing Union Pharmaceutical Factory
• DIRECTORY

India Pharmaceutical Market Intelligence Report

• EXECUTIVE SUMMARY
• PHARMACEUTICAL MARKET
• Current Size
• Projections
• Outlook
• Market Structure
  • Domestic production
  • Multinationals
  • Trade Associations
  • Pharmaceutical Imports
  • Raw Material Imports
  • Finished Medicament Imports
  • Exports
  • Research & Development
  • Traditional Indian Medicines
• Market Developments
  • Pfizer becomes first MNC to get Indian patent for anti-AIDS drug
  • Indian government cracks down on overcharging
  • Novartis' s challenge to Indian patent law dismissed by High Court
  • Satwant Reddy Committee Report on Data Protection, May 2007
  • Mashelkar Committee Report, December 2006
  • India may have overestimated HIV/AIDS burden
  • India ranks top in contract research
  • Drugs (Prices Control) Amendment Order and Second Amendment Order, 2006
  • The Patents (Amendment) Rules 2006
  • Government Task Force on Drug Pricing
  • National Pharmaceuticals Policy 2006
• KEY NATIONAL DATA PROJECTIONS
• Methodology and Sources
• Trade Code Classifications

List of Tables

• Summary of the Indian Pharmaceutical Market in 2007
• Projected Pharmaceutical Market, 2007-2012
• SWOT Analysis of the Indian Pharmaceutical Market
• Analysis of India' s Health Sector
• Global Sales by Leading Domestic Companies, 12 months ended 31st March 2007
• Pharmaceutical Import Summary, 2001-2005 (US$000s)
• Leading Suppliers, 2005 (US$000s)
• Leading Suppliers of Raw Materials, 2005
• Leading Suppliers of Finished Medicaments, 2005
• Imports of Pharmaceuticals, 2001-2005 (US$000s)
• Pharmaceutical Import Trends
• Leading Suppliers, 2005 (US$000s)
• Leading Suppliers by Category, 2005 (US$000s)
• Pharmaceutical Export Summary, 2001-2005 (US$000s)
• Exports of Pharmaceuticals, 2001-2005 (US$000s)
• Pharmaceutical Export Trends
• Pharmaceutical Exports by Destination, 2005 (US$000s)
• Balance of Trade in Pharmaceuticals, 2001-2005 (US$000s)
• Key Data Projections, 2007-2012

INDIA BACKGROUND DATA

• GEOGRAPHY
• POLITICAL OVERVIEW
• ECONOMIC OVERVIEW
• POPULATION
  • Population by States and Territories, 2001-2007
• DEMOGRAPHIC INDICATORS
  • Demographic Indicators, 1996-2006
  • Demographic Indicators by State, 2006
• MORTALITY
  • Medically Certified Deaths by Cause, 2000
  • Major Causes of Death, Rural India 1993-1998
  • Deaths from Non-Communicable Diseases, 1998
• MORBIDITY
• National Rural Health Mission
• Child Survival and Safe Motherhood
  • Reproductive and Child Health Programme
  • Universal Immunisation Programme
    • Reported Incidence of Vaccine Preventable Diseases, 1985-2006
  • Reducing Fertility
    • Family Planning
    • All India Hospitals Post-Partum Programme
• National Health Programmes for Disease Control/Eradication
  • National Vector Borne Disease Control Programme
    • Malaria
      • Reported Malaria Incidence & Deaths, 1996-2006
    • Filariasis
    • Kala-azar
      • Reported Kala-azar Cases & Deaths, 1996-2006
    • Japanese Encephalitis
      • Suspected Japanese Encephalitis Cases & Deaths, 2000-2006
  • National Programme for the Control of Blindness
  • National Leprosy Eradication Programme
  • National Tuberculosis Control Programme
  • HIV/AIDS
    • National AIDS Control Programme
  • Cancer
    • Leading Cancer Sites in Males (HBCR), 2001-2003
    • Leading Cancer Sites in Females (HBCR), 2001-2003

CHARTS

• Map of India
• Population by Age Group, 2006 (%)
• Medically Certified Deaths by Cause, 2000

INDIA HEALTHCARE SYSTEM

• ORGANISATION & ADMINISTRATION
• Department of Health and Family Welfare
• The Department of AYUSH
• Health Insurance
  • Apollo Family Health Plan
• HEALTH EXPENDITURE
  • Health Expenditure by Source of Funds, 2001/02
  • Department of Health & Family Welfare: Health Sector Expenditure by Scheme, 2005/06
• HOSPITAL SERVICES
• Hospital Resources
  • Hospitals & Beds by State & Sector, 2002
  • Government Hospitals/CHCs and Beds by State, 2007
  • Hospitals, Dispensaries & Beds, 1991-1998
  • Beds in Selected Hospitals, 2006
  • All India Institute of Medical Sciences (AIIMS)
    • AIIMS Hospital Beds, 2005/06
    • AIIMS Hospital Activity, 2005/06
    • AIIMS Inpatients by Specialty, 2005/06
  • Safdarjung Hospital, New Delhi
    • Safdarjung Hospital Beds by Specialty, 2003
  • Dr. Ram Manohar Lohia Hospital, New Delhi
    • Dr. Ram Manohar Lohia Hospital Beds by Specialty, 2000/01
  • JIPMER Hospital, Pondicherry
    • JIPMER Hospital Beds by Specialty, 2000
  • PGIMER Nehru Hospital, Chandigarh
    • PGIMER Nehru Hospital Beds by Specialty, 2004/05
  • Lady Hardinge Medical College Associated Hospitals, New Delhi
• Private Hospitals and Clinics
  • Apollo Hospitals Group
  • Fortis Healthcare
  • Max Healthcare
  • Other Commercial Providers
• AMBULATORY CARE
  • Sub-centres and Primary Health Centres, 2004-2006
  • CGHS Out-patient Facilities, 31st March 2006
• First Aid and Disaster Relief
  • St. John Ambulance
  • Indian Red Cross Society
• Healthcare for the Underprivileged, Scheduled Castes and Scheduled Tribes
  • Healthcare Infrastructure in Tribal/Scheduled Caste Areas, 1995-2005
• Medical Care for Remote & Marginalised Tribal & Nomadic Communities
• MEDICAL PERSONNEL
  • Doctors Registered with State Medical Councils, 1995-2005
  • Registered Dental Surgeons, 1995-2005
  • Registered Nursing Personnel, 1995-2005
  • Healthcare Personnel in Rural Areas, 1998-2006

CHARTS

• Health Expenditure by Source, 2001/02 (%)

INDIA ACCESSING THE PHARMACEUTICAL MARKET

• INTRODUCTION
• REGULATORY ENVIRONMENT
• National Pharmaceuticals Policy 2006
• Pharmaceutical Registration
• Advertising
• Patent Protection & Intellectual Property Rights
  • Background to Pharmaceutical Patents
  • Mashelkar Committee Report, December 2006
  • The Patents (Amendments) Bill, 2005
    • Compulsory Licensing
    • Pre- & Post-Grant Opposition
    • Mailbox Applications
    • Other Issues
  • The Patents (Amendment) Rules 2006
  • Previous Patents Act Amendments and Exclusive Marketing Rights
    • Glivec/Gleevec Patent Setback for Novartis
• Pricing
  • Drugs (Prices Control) Amendment Order and Second Amendment Order, 2006
  • Drug Price Control Review Committee
• DISTRIBUTION CHANNELS
  • Medical Stores Organisation
• TRADE FAIRS
  • Biotech India 2007
  • India Chem 2008
  • Pharma Bio World Expo 2009
• DOMESTIC PRODUCTION
  • Global Sales by Leading Domestic Companies, 12 months ended 31st March 2007
• BCG Vaccine Laboratory, Chennai
• Trade Associations
• Domestic Producers
  • Alembic Ltd
    • Alembic: Manufacturing Facilities
    • Alembic Financial Results, 2003-2007
  • Aurobindo Pharma
    • Aurobindo Pharma: Manufacturing Facilities
    • Aurobindo Pharma: ANDA Approvals, 2004-2008
    • Cephazone Pharma: FDA ANDA Approval, 2007
    • Aurobindo Pharma: Financial Results, 2003-2007
  • Biocon
    • Biocon Financial Results, 2003-2007
  • Blue Cross Laboratories Ltd
  • Cipla Ltd
    • Cipla: Manufacturing Facilities
    • Cipla: FDA ANDA Approvals, 2007
    • Cipla: Tentative FDA ANDA Approvals
    • Cipla: Tentative FDA NDA Approvals
    • Cipla: Financial Results, 2003-2007
  • Dr. Reddy' s Laboratories Ltd
    • Dr. Reddy' s: Manufacturing Facilities
    • Dr. Reddy' s: FDA ANDA Approvals, 2002-2008
    • Dr. Reddy' s: Financial Summary, 2003-2007
  • Glenmark Pharmaceuticals
    • Glenmark: Manufacturing Facilities
    • Glenmark: FDA ANDA Approvals, 2006-2007
    • Glenmark: Financial Results, 2003-2007
  • Lupin Limited
    • Lupin: Manufacturing Facilities
    • Lupin: FDA ANDA Approvals 2003-2008
    • Lupin: Tentative FDA Approvals
    • Lupin: Financial Results, 2003-2007
  • Matrix Laboratories
    • Matrix: Manufacturing Facilities
    • Matrix FDA ANDA Approval, 2008
    • Matrix: Tentative FDA ANDA Approvals
    • Matrix: Financial Results, 2003-2007
  • Natco Pharma
    • Natco Pharma Financial Results, 2003-2007
  • Nicholas Piramal India Ltd
    • NPIL: Manufacturing Facilities
    • NPIL: Financial Results, 2003-2007
  • Orchid Chemicals & Pharmaceuticals Ltd
    • Orchid: Manufacturing Facilities
    • Orchid' s Top-10 Brands
    • Orchid: FDA ANDA Approvals, 2005-2008
    • Orchid: Financial Results, 2003-2007
  • Ranbaxy Laboratories Ltd
    • Ranbaxy: Manufacturing Facilities
    • Ranbaxy Laboratories: FDA ANDA Approvals, 2002-2007
    • Ohm Laboratories: FDA ANDA Approvals, 2006-2007
    • Ranbaxy Financial Results, 2003-2007
  • Sun Pharma
    • Sun Pharma: Manufacturing Facilities
    • Sun Pharma: FDA ANDA Approvals, 2006-2007
    • Caraco Pharmaceutical: ANDA Approvals, 2002-2008
    • Sun Pharma: Financial Results, 2003-2007
  • Wockhardt Ltd
    • Wockhardt Manufacturing Facilities
    • Wockhardt: FDA ANDA Approvals, 2003-2008
    • Wockhardt: Financial Results, 2003-2006
  • Zydus Cadila
    • Zydus Cadila: Manufacturing Facilities
    • Zydus: ANDA Approvals, 2005-2008
    • Zydus Cadila: Consolidated Results, 2006-2007
    • Cadila Healthcare: Financial Results, 2003-2007
    • Zydus Cadila: Domestic Formulations Sales by Therapy Area, 2006
  • Multinational Activity
  • Actavis
  • GlaxoSmithKline
  • Pfizer India
  • sanofi-aventis
• Research & Development
  • New Millennium Indian Technology Leadership Initiative
  • Indian Council of Medical Research
  • Central Research Institute, Kasauli
  • Central Drug Research Institute, Lucknow
  • Central Council for Research in Unani Medicine
  • Central Council for Research in Ayurveda and Siddha
  • Central Council for Research in Homeopathy
• Traditional Indian Medicines
  • Components
  • Ayurvedic Supply
• DIRECTORY
• Government Organisations
• Trade Associations

CHARTS

• Cipla: Exports by Region, 2007 (%)
• Dr. Reddy' s: Sales by Region, 2007 (%)
• Glenmark: Formulations Sales by Region, 2007 (%)
• Matrix: Sales by Region, 2006 (%)
• Orchid: API Sales by Region, 2007 (%)
• Orchid: Formulations Sales by Region, 2007 (%)
• Wockhardt: Sales by Region, 2006 (%)
• Zydus Cadila: Sales by Region, 2007 (%)

Russia Pharmaceutical Market Intelligence Report

• EXECUTIVE SUMMARY
• PHARMACEUTICAL MARKET
• Current Size
• Projections
• Outlook
• Market Structure
  • Pharmacy Market
  • Hospital Market
  • Generics
  • OTC Market
  • Domestic Production
  • Multinationals
  • Imports
  • Exports
  • Research & Development
• Market Developments
  • Obligatory Medical Insurance (OMI)
  • Drug Reimbursement System
    • DLO Market in Q1-Q3 2006
  • Clinical Trials
  • Corruption within the Health Insurance System
  • Medicines Budget Increased
  • 2006-2008 Budget
  • Counterfeit Drugs
  • HIV/AIDS Report Indicates Worsening Epidemic
  • Talks with Belarus to Strengthen Drug Trade
  • Guaranteed Medical Services
  • World Bank Projects
    • Health Reform Implementation Project
    • TB & AIDS Control Project
• KEY NATIONAL DATA PROJECTIONS
• Methodology and Sources

List of Tables

• Summary of the Russian Pharmaceutical Market in 2007
• Projected Pharmaceutical Market, 2007-2012
• SWOT Analysis of the Russian Pharmaceutical Market
• Espicom Analysis of the Russian Healthcare Sector
• Top Ten ATC Groups by Pharmacy Sales Value, 2003-2005 (%)
• Top Ten ATC Groups by Hospital Purchases, 2003-2005 (%)
• Generic and Original Drugs by Market Share, 2004-2007 (%)
• Generic and Original Drugs in the DLO Market by Share, 2005-2007 (%)
• Top Ten Generic Drugs in the Retail Sector, Q1-Q2 2007
• Top Ten Generic Companies, Q1-Q2 2007
• Top Ten Manufacturers, Trade Names and ATG Groups in the OTC Market, 2005
• Top Ten Domestic Producers, 2006 (US$ millions)
• Russian Pharmaceutical Output, 2000-2003 (US$ millions)
• Top Pharmaceutical Companies by Sales, 2004-2006 (%)
• Pharmaceutical Imports, 2001-2005 (US$000s)
• Leading Suppliers of Raw Materials, 2005 (US$000s)
• Leading Suppliers of Medicaments, 2005 (US$000s)
• Pharmaceutical Imports, 2001-2005 (US$000s)
• Pharmaceutical Import Trends, 2005 (US$000s)
• Leading Suppliers, 2005 (US$000s)
• Leading Suppliers by Category, 2005 (US$000s)
• Pharmaceutical Exports, 2001-2005 (US$000s)
• Exports of Pharmaceuticals, 2001-2005 (US$000s)
• Exports by Leading Destination, 2005 (US$000s)
• Pharmaceutical Balance of Trade, 2001-2005 (US$000s)
• Top 10 ATCs Purchased under the Federal Budget, 2006
• Top 10 Manufacturers by DLO Value, 2005-2006
• Top 10 Products by DLO Value, 2005-2006 (%)
• Top 10 ATC Groups by DLO Value, 2005-2006 (%)
• Key Data Projections, 2007-2012

List of Figures

• Pharmaceutical Imports, Exports & Balance of Trade, 1998-2005 (US$000s)
• Percentage Change in Imports and Exports, 1999-2005
• Market Projections, 2007-2012
• Radar Graph of the Russian Healthcare System
• Imports by Category, 2005 (%)
• Leading Suppliers, 2005 (%)
• Exports by Category, 2005 (%)

RUSSIA BACKGROUND DATA

• GEOGRAPHY
• POLITICAL OVERVIEW
• ECONOMIC OVERVIEW
  • Economic Indicators, 1995-2012
• POPULATION
  • Population by Age and Sex, 2006
  • Population by District, 2001
• DEMOGRAPHIC INDICATORS
  • Principal Demographic Indicators, 1995-2005
• MORTALITY
  • Deaths by Cause, 2004-2005
    • Infant Mortality
  • Infant Mortality by Cause, 2004-2005
• MORBIDITY
  • Incidence of Morbidity by Diagnosis, 2005 (000)
  • Incidence of Morbidity by Diagnosis, 2000-2005 (000)
• Infectious Diseases
  • Infectious Diseases, 2000-2001
    • Tuberculosis
    • HIV/AIDS
  • Reported Cases of HIV, 2000-2005

CHARTS

• Map of Russia
• Population, 1989-2006 (millions)
• Population by Age Group, 2006 (%)
• Leading Causes of Death, 2005 (%)

RUSSIA HEALTHCARE SYSTEM

• ORGANISATION & ADMINISTRATION
• HEALTH EXPENDITURE
  • Hospital funding change proposed
• HOSPITAL SERVICES
  • Public Hospitals, 1996-2005
  • Hospital Beds, 1997-2005
• MoH Facilities
  • MOH Inpatient Facilities, 2002-2005
  • Public Hospital Beds by Specialty, 2003-2005
• Hospital Activity
  • Hospital Discharges by Group of Diseases, 2002-2005
  • Hospital Activity, 1998-2005
  • Bed Occupancy (Days) By Type of Hospital, 1999-2001
    • Surgical procedures
  • Surgical Operations In Hospitals, 2003-2005
• AMBULATORY CARE
  • Outpatient Care Facilities, 1997-2005
• MoH Facilities
  • Outpatient Facilities and Polyclinics, 2002-2005
  • Surgical Operations in Polyclinics & Outpatient Units, 2000-2005
  • Surgical Operations in Polyclinics, 2000-2001
• Day Surgery
  • Day Surgeries, 2003-2005
  • Day Surgery Discharges by Group of Diseases, 2003-2005
• MEDICAL PERSONNEL
  • MoH Medical Personnel, 1998-2005
  • MoH Doctors by Type, 2002-2004
  • MoH Doctors by Leading Specialty, 2002-2005 (000s)

RUSSIA ACCESSING THE PHARMACEUTICAL MARKET

• INTRODUCTION
• REGULATORY ENVIRONMENT
  • VAT on Pharmaceuticals
• Pharmaceutical Registration
• Import Regulations
• Advertising
• Patent Protection & Intellectual Property Rights
  • Counterfeit Medicines
• Pricing and Reimbursement
  • Drug Pricing
  • Reimbursement
• DISTRIBUTION CHANNELS
• Distributors
  • Protek
  • Shreya Corporation
  • SIA International
• TRADE FAIRS
  • Hospital
  • Pharmtech 2006
• DOMESTIC PRODUCTION
  • Top Ten Domestic Producers, 2006 (US$ millions)
  • Russian Pharmaceutical Output, 2000-2003 (US$ millions)
• Trade Associations
  • AIPM
• Domestic Producers
  • Akrikhin
  • Bryntsalov A
  • JSC Farmacon
  • KRKA
  • Nizhpharm
• Nizhpharm Sales, 1999-2003
  • Otechestvennye Lekarstva (Erka Farm)
  • Pharmstandard
  • Veropharm
  • Yugrafarm
• Multinationals
  • Top Pharmaceutical Companies by Sales, 2004-2006 (%)
• Research & Development
• DIRECTORY
• Government Organisations
• Regional Health Authorities
• Trade Associations